Close Menu

NEW YORK – The US Food and Drug Administration issued a letter on Monday alerting clinical labs and healthcare providers about two concerns related to a COVID-19 test from Thermo Fisher Scientific.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.